Elevated triglycerides and low HDL cholesterol in transgenic mice expressing human apolipoprotein A-I(Milano)

Atherosclerosis
G ChiesaE M Rubin

Abstract

In general, plasma concentrations of high density lipoproteins (HDL) are inversely related to the incidence of coronary artery disease. One exception to this trend is individuals with apolipoprotein A-I(Milano) (apo A-IM), a molecular variant of apo A-I, which results in very low plasma apo A-I and HDL-cholesterol levels. Despite these low levels, and other lipoprotein defects, individuals with this mutation have no increased risk for cardiovascular disease. As a first step in proving why apo A-IM carriers appear to be protected from the pro-atherogenic effect of a low HDL, transgenic mice expressing apo A-IM were generated. Mice expressing either wild-type human apo A-I or apo A-IM, together with human apo A-II, were crossed into mice lacking murine apo A-I. Apo A-IM/A-II mice had lower cholesterol and HDL plasma levels compared to apo A-I/A-II mice. Moreover, as in human carriers, apo A-IM mice were characterized by elevated triglyceride plasma levels and by the presence of a population of very small HDL particles. These results indicate that the expression of apo A-IM in a mouse model reproduces the major lipid/lipoprotein abnormalities observed in human carriers. Thus, apo A-IM transgenic mice appear to be a suitable model ...Continue Reading

References

Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·R WilliamsonN Maeda
Jul 1, 1987·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·G FranceschiniA V Nichols
Nov 1, 1987·Atherosclerosis·P PuchoisJ C Fruchart
May 1, 1986·Metabolism: Clinical and Experimental·M R LovatiC R Sirtori
Jan 1, 1986·Methods in Enzymology·A V NicholsT A Musliner
Feb 1, 1985·The Journal of Clinical Investigation·C S WangP Alaupovic
Sep 1, 1996·European Journal of Clinical Investigation·G Franceschini
Mar 17, 1997·Biochemical and Biophysical Research Communications·L CalabresiA Jonas

❮ Previous
Next ❯

Citations

Apr 29, 2000·Current Opinion in Lipidology·A D Kalopissis, J Chambaz
May 4, 2007·Cardiovascular Diabetology·Corinna LebherzDaniel J Rader
Oct 8, 1999·Clinica Chimica Acta; International Journal of Clinical Chemistry·P Duriez, J C Fruchart
Dec 11, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Yingmei FengBart De Geest
Sep 29, 2011·Biochimica Et Biophysica Acta·Mary G Sorci-ThomasMichael J Thomas
Jun 28, 2005·International Journal of Cardiology·Tiziana SampietroAlberto Bionda
May 14, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·G FranceschiniF Bernini
Nov 5, 2013·Current Opinion in Lipidology·Brian R Krause, Alan T Remaley
Dec 15, 2020·Metabolism: Clinical and Experimental·Alice OssoliLaura Calabresi

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.